You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

atherosclerotic inflammation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Atherosclerosis of Artery, Coronary Artery Disease, Peripheral Arterial Disease Trial in Seoul (Rivaroxaban 2.5mg)

Recruiting
  • Atherosclerosis of Artery
  • +3 more
  • Rivaroxaban 2.5mg
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 2, 2023

Understand Real-world Awareness and Perceptions for Systemic

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease (ASCVD)
  • Chronic Kidney Disease (CKD)
  • No treatment given
  • Bangalore, India
    Novo Nordisk Investigational Site
Feb 23, 2023

Inflammation in People With Cardiovascular Disease (POSEIDON)

Not yet recruiting
  • Cardiovascular Risk
  • +2 more
  • No treatment given
  • (no location specified)
Nov 3, 2023

Immunomodulatory Effects of PCSK9 Inhibition

Not yet recruiting
  • Atherosclerotic Cardiovascular Disease
  • +3 more
  • Contrast-enhanced CCTA
  • 99mTc-tilmanocept SPECT/CT scanning
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 30, 2023

Atherosclerosis, Stress, Inflammation Trial in Boston (Stress Reduction)

Recruiting
  • Atherosclerosis
  • +2 more
  • Stress Reduction
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 17, 2022

Coronary Artery Disease, Coronary Artery Stenosis, Coronary Artery Restenosis Trial (behavioral, drug, procedure)

Not yet recruiting
  • Coronary Artery Disease
  • +6 more
  • Healthy life style
  • +4 more
  • (no location specified)
May 8, 2023

Atherosclerosis of Artery, Peripheral Artery Disease, Diabetes Trial in Changsha, Jinan (N-acetylcysteine, Placebo)

Withdrawn
  • Atherosclerosis of Artery
  • +4 more
  • Changsha, Hunan, China
  • +1 more
Jun 9, 2023

Atherosclerosis, Coronary, Emotional Stress, Inflammation Trial in Seoul (OCT-FLIM (optical coherence tomography-fluorescence

Recruiting
  • Atherosclerosis, Coronary
  • +7 more
  • OCT-FLIM (optical coherence tomography-fluorescence life time)
  • Seoul, Korea, Republic of
    Korea University Guro Hospital
Aug 22, 2022

Periodontal Disease, Inflammation and Acute Coronary Syndromes

Completed
  • Coronary Stenosis
  • +7 more
  • cardiac imaging tests
  • Târgu-Mureş, Mures, Romania
    Cardio Med
Jul 30, 2022

Coronary Artery Disease, Atherosclerosis, Coronary, Hiv Trial in Moscow (Quantitative coronary angiography, intravascular

Enrolling by invitation
  • Coronary Artery Disease
  • +4 more
  • Quantitative coronary angiography, intravascular imaging with percutaneous intervention
  • Moscow, Russian Federation
  • +1 more
Mar 12, 2022

Coronary Artery Disease Trial (Ticagrelor)

Completed
Has Results
  • Coronary Artery Disease
  • (no location specified)
Mar 11, 2021

Acute Coronary Syndrome, Atherosclerosis Trial in Madrid (procedure, genetic, other)

Completed
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Assessment of the atherosclerotic plaque in a moderate lession.
  • +4 more
  • Madrid, Spain
    Hospital General Universitario Gregorio Maranon
Aug 3, 2021

Coronary Artery Disease, Atherosclerosis, Inflammation Trial in São Paulo (LDE-Paclitaxel, LDE-Placebo)

Unknown status
  • Coronary Artery Disease
  • +2 more
  • São Paulo, SP, Brazil
    Heart Institute (InCor) - University of São Paulo Medical School
Oct 24, 2020

Atherosclerosis, Coronary Artery Disease, Inflammation Trial in São Paulo (Methotrexate-LDE, Placebo-LDE)

Recruiting
  • Atherosclerosis
  • +2 more
  • São Paulo, SP, Brazil
  • +1 more
Nov 7, 2020

PTSD, Trauma, Healthy Trial in Boston, New York (fluorodeoxyglucose (FDG)-PET/MRI)

Recruiting
  • PTSD
  • +2 more
  • fluorodeoxyglucose (FDG)-PET/MRI
  • Boston, Massachusetts
  • +1 more
Aug 29, 2022

Atherosclerotic Vascular Disease Trial in Montreal (Colchicine, Placebo)

Completed
  • Atherosclerotic Vascular Disease
  • Montreal, Quebec, Canada
    Montreal Heart Institute
Feb 20, 2020

Vascular Inflammation, Atherosclerotic Cardiovascular Disease Trial in Boston, New York, Toronto (Low dose methotrexate,

Completed
Has Results
  • Vascular Inflammation
  • Atherosclerotic Cardiovascular Disease
  • Low dose methotrexate
  • Placebo
  • Boston, Massachusetts
  • +2 more
Apr 9, 2020

Diabetes, Type 2, Dyslipidemias, Hypertension Trial in Cairo (Puritans Pride Turmeric curcumin® 500 mg)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • +2 more
  • Puritans Pride Turmeric curcumin® 500 mg
  • Cairo, Egypt
    Demerdash Hospital, Faculty of Medicine, Ain Shams University
Mar 1, 2023

Fast, Semi-Automated Hybrid Imaging Platform to Assess Coronary

Unknown status
  • Stable Angina
  • Coronary Artery Disease
  • PET-CT
  • (no location specified)
Dec 19, 2019

Long-term Evaluation

Recruiting
  • Atherosclerosis
  • +3 more
  • PET imaging
  • +2 more
  • Cambridge, United Kingdom
    University of Cambridge
Mar 18, 2022

Hypercholesterolemia, Hypercholesterolemia, Familial Trial in Cambridge (PCSK9 inhibitor, 68Ga-DOTATATE PET-MRI)

Not yet recruiting
  • Hypercholesterolemia
  • +3 more
  • Cambridge, United Kingdom
    University of Cambridge
Jan 13, 2023

Atherosclerotic Vascular Disease, Type2 Diabetes, Microvascular Dysfunction Trial in New York, Toronto (Placebo, Evolocumab)

Completed
  • Atherosclerotic Vascular Disease
  • +2 more
  • New York, New York
  • +1 more
Jul 11, 2022

Rheumatoid Arthritis Disease Activity and Sub Clinical

Completed
  • Rheumatoid Arthritis
    • Assiut, Egypt
      Assiut university hospital
    Jan 23, 2023

    Diabetes, Acute Coronary Syndrome, Coronary Artery Disease Trial (radiation, procedure, other)

    Recruiting
    • Diabetes Mellitus
    • +2 more
    • A computerized tomography (CT) coronary angiogram
    • +2 more
    • Swansea, United Kingdom
      Swansea Bay University Health Board
    Oct 25, 2022

    Atherosclerosis, Peripheral Arterial Disease Trial in Moscow (Allicor, Placebo)

    Not yet recruiting
    • Atherosclerosis
    • Peripheral Arterial Disease
    • Allicor
    • Placebo
    • Moscow, Russian Federation
      Institute for Atherosclerosis Research
    Apr 16, 2023